Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Monica, Else"'
Autor:
Farhad Ravandi, Robert J. Kreitman, Enrico Tiacci, Leslie Andritsos, Versha Banerji, Jacqueline C. Barrientos, Seema A. Bhat, James S. Blachly, Alessandro Broccoli, Timothy Call, Dai Chihara, Claire Dearden, Judit Demeter, Sasha Dietrich, Monica Else, Narendranath Epperla, Brunangelo Falini, Francesco Forconi, Douglas E. Gladstone, Alessandro Gozzetti, Sunil Iyengar, James B. Johnston, Jeffrey Jorgensen, Gunnar Juliusson, Francesco Lauria, Gerard Lozanski, Sameer A. Parikh, Jae H. Park, Aaron Polliack, Graeme Quest, Tadeusz Robak, Kerry A. Rogers, Alan Saven, John F. Seymour, Tamar Tadmor, Martin S. Tallman, Constantine S. Tam, Philip A. Thompson, Xavier Troussard, Clive S. Zent, Thorsten Zenz, Pier Luigi Zinzani, Bernhard Wörmann, Kanti Rai, Michael Grever
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 12, Pp 1-7 (2022)
Abstract A significant body of literature has been generated related to the detection of measurable residual disease (MRD) at the time of achieving complete remission (CR) in patients with hairy cell leukemia (HCL). However, due to the indolent natur
Externí odkaz:
https://doaj.org/article/b522c851a9074f98bd78424982d9e633
Autor:
Tomasz K. Wojdacz, Harindra E. Amarasinghe, Latha Kadalayil, Alice Beattie, Jade Forster, Stuart J. Blakemore, Helen Parker, Dean Bryant, Marta Larrayoz, Ruth Clifford, Pauline Robbe, Zadie A. Davis, Monica Else, Dena R. Howard, Basile Stamatopoulos, Andrew J. Steele, Richard Rosenquist, Andrew Collins, Andrew R. Pettitt, Peter Hillmen, Christoph Plass, Anna Schuh, Daniel Catovsky, David G. Oscier, Matthew J.J. Rose-Zerilli, Christopher C. Oakes, Jonathan C. Strefford
Publikováno v:
Blood Advances, Vol 3, Iss 16, Pp 2474-2481 (2019)
Abstract: Chronic lymphocytic leukemia patients with mutated immunoglobulin heavy-chain genes (IGHV-M), particularly those lacking poor-risk genomic lesions, often respond well to chemoimmunotherapy (CIT). DNA methylation profiling can subdivide earl
Externí odkaz:
https://doaj.org/article/cd01b8a978aa4041a72a417cc4cb4fcc
Autor:
Alessandro Broccoli, Lisa Argnani, Matthew Cross, Agnieszka Janus, Elsa Maitre, Xavier Troussard, Tadeusz Robak, Claire Dearden, Monica Else, Daniel Catovsky, Pier Luigi Zinzani
Publikováno v:
Blood Advances. 6:4224-4227
Key Points Cladribine is regarded as the first treatment of choice for symptomatic hairy cell leukemia. This large international study reports a complete response in 72% of cases and a continuous complete response in 20% of patients.
Publikováno v:
Leukemia
Causes of death, in particular deaths due to infection, have not been widely studied in randomised trials in chronic lymphocytic leukaemia. With long-term follow-up (median 13 years) we examined the cause of death in 600/777 patients in the LRF CLL4
Autor:
Daniel Catovsky, Lisa Argnani, E. Maitre, A. Janus, P. L. Zinzani, Xavier Troussard, Monica Else, Tadeusz Robak, Claire Dearden, M. Cross, Alessandro Broccoli
Publikováno v:
Hematological Oncology. 39
Publikováno v:
Haematologica, Vol 99, Iss 6 (2014)
We examined the prognostic influence of gender in chronic lymphocytic leukemia. Data from four randomized trials (involving 1821 patients) and three registration studies of stage-A disease (involving 1299 patients) were analyzed. Overall survival at
Externí odkaz:
https://doaj.org/article/a4574636a5eb447cb028ba2086581edd
Autor:
David Gonzalez, Monica Else, Dorte Wren, Monica Usai, Anne Mette Buhl, Anton Parker, David Oscier, Gareth Morgan, Daniel Catovsky
Publikováno v:
Haematologica, Vol 98, Iss 2 (2013)
CLLU1, located at chromosome 12q22, encodes a transcript specific to chronic lymphocytic leukemia and has potential prognostic value. We assessed the value of CLLU1 expression in the LRF CLL4 randomized trial. Samples from 515 patients with chronic l
Externí odkaz:
https://doaj.org/article/2604ec1d4bdc4014b4a6b844755e034f
Autor:
Daniel, Catovsky, Monica, Else
Publikováno v:
British journal of haematologyReferences. 191(4)
This is an historical account of the randomised trials in chronic lymphocytic leukaemia in the UK between the years 1978 to 2004, describing their gestation, the treatments used and the main lessons learnt. Those lessons include: (1) how best to use
Autor:
David Oscier, Rachel Wade, Zadie Davis, Alison Morilla, Giles Best, Sue Richards, Monica Else, Estella Matutes, Daniel Catovsky
Publikováno v:
Haematologica, Vol 95, Iss 10 (2010)
Background Many prognostic markers have been identified in chronic lymphocytic leukemia, but there have been few opportunities to assess their relative importance in a large randomized trial. The aim of this study was to determine which of the availa
Externí odkaz:
https://doaj.org/article/fce1856397524948811b2f7cb9418b9b
Publikováno v:
Blood. 136:37-38
* These authors contributed equally Introduction Causes of death and, in particular, deaths due to infection have not been widely studied in randomised trials in chronic lymphocytic leukaemia (CLL). With long-term follow-up (median 13 years), we were